Recurrence patterns and site-level survival in the previous phase III study of IL13-PE38QQR: Implications for drug distribution variability.

Category Primary study
ConferenceASCO Gastrointestinal Cancers Symposium
Year 2026
This article has no abstract
Epistemonikos ID: ae80a08f0fe6da385b2a6f04f02fdd94c8c66688
First added on: Jul 18, 2026